Evidence map›Paper›PMID 34866192›Full record

ReviewImmunological reviews2022

Visualization and functional characterization of lymphoid organ fibroblasts.

Lucas Onder, Hung-Wei Cheng, Burkhard Ludewig

Open access · greenAbstract readReview
In one paragraph

Review in Immunological reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Lymphoid stroma in all its states.Frontiers in immunology · 2025
    Review
  11. Review
  12. Article
  13. Article
  14. Fibroblasts in liver cancer: functions and therapeutic translation.The lancet. Gastroenterology & hepatology · 2023
    Review
  15. PI16Nature immunology · 2023
    Article
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lucas OnderInstitute of Immunobiology, Medical Research Center, Kantonsspital St.Gallen, St.Gallen, Switzerland.
Hung-Wei ChengInstitute of Immunobiology, Medical Research Center, Kantonsspital St.Gallen, St.Gallen, Switzerland.
Burkhard LudewigInstitute of Immunobiology, Medical Research Center, Kantonsspital St.Gallen, St.Gallen, Switzerland.ORCID 0000-0002-7685-573X
Kantonsspital St. Gallen · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibroblastic reticular cells (FRCs) are specialized stromal cells of lymphoid organs that generate the structural foundation of the tissue and actively interact with immune cells. Distinct FRC subsets position lymphocytes and myeloid cells in specialized niches where they present processed or native antigen and provide essential growth factors and cytokines for immune cell activation and differentiation. Niche-specific functions of FRC subpopulations have been defined using genetic targeting, high-dimensional transcriptomic analyses, and advanced imaging methods. Here, we review recent findings on FRC-immune cell interaction and the elaboration of FRC development and differentiation. We discuss how imaging approaches have not only shaped our understanding of FRC biology, but have critically advanced the niche concept of immune cell maintenance and control of immune reactivity.

Indexed as

FibroblastsStromal CellsCell CommunicationCell DifferentiationGene Expression ProfilingHumansLymph Nodescell-fate mappingfibroblastic reticular cellsimmune cell nicheslineage tracingtransgenic mouse models

Identifiers

PMID34866192
PMCPMC9300201
OpenAlexW4200507446

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.